Recently, Porton Advanced proudly announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome ...

Recently, ACROBiosystems has officially received the 'Material Suitability Confirmation for Regenerative Medicine Products' (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices ...

Indian companies filed 184 Type II DMFs with the US FDA in Q1 2026 against China's 149, reinforcing the country's leadership in API manufacturing and future generic drug development ...

The timing could not be more significant. According to the National Mental Health Survey 2015–16, conducted by NIMHANS across ...

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S.

Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...

Strategic collaboration at Sanford, North Carolina facility, currently under construction, to optimize cGMP validation, accelerate time-to-market ...

Leiutis Pharmaceuticals' newly approved medicine contains a fully synthetic cannabidiol (CBD) active pharmaceutical ...

Officers told to identify places where poaching occurred, and hold awareness programmes for staff about wildlife conservation ...

Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder (SAD), cratering its share price, despite the company's assertions that there may be a way ...

SL Science Holding Limited ('SL Science” or the 'Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced ...

UPSC Drug Inspector recruitment 2026: The Union Public Service Commission (UPSC) has released the notification for the recruitment of 186 Drug Inspectors in the Central Drugs Standard Control ...